Synonyms: Anti-106 kDa O-GlcNAc transferase-interacting protein; Anti-Trafficking kinesin-binding protein 1
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Trafficking kinesin-binding protein 1 is a protein encoded by the TRAK1 gene in humans. It is referred as MILT1 and OIP106. This gene may target O-GlcNAc transferase (OGT) to transcriptional complexes for glycosylation of transcriptional proteins (such as RNA polymerase II and transcription factors). It acts as a crucial regulator of GABA(A) receptor homeostasis. It may play an important role in the development of CRC and may act as a valuable prognostic indicator of CRC.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC